Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Vomiting × Tablets × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3 Vomiting 1 Prostatic Neoplasms 1 Parathyroid Neoplasms 1 Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1 Hyperparathyroidism, Primary 1 Hot Flashes 1 Erectile Dysfunction 1 Diabetes Mellitus 1 Carcinoma, Renal Cell 1

Interventions

Dexamethasone 22 Ondansetron 12 Palonosetron 11 Aprepitant 9 Granisetron 7 Olanzapine 5 ramosetron 3 netupitant, palosentron drug combination 3 casopitant 3 Radiotherapy 3 fosaprepitant 2 Thalidomide 2 Prochlorperazine 2 Electroacupuncture 2 Dronabinol 2 Analgesia 2 Acupressure 2 sinomenine 1 netupitant 1 lerisetron 1 dolasetron 1 dexamethasone acetate 1 Tropisetron 1 Therapeutics 1 Taxes 1 Tablets 1 Surveys and Questionnaires 1 Sugars 1 Metoclopramide 1 Hygiene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04232423 2022-01-21

OLN-EME

Department of Medical Services Ministry of Public Health of Thailand

Phase 3 Completed

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡